Literature DB >> 23943575

Surgical placement of totally implantable venous access device-an institutional experience.

Aravindan Chandrasekaran1, Jayabose Somasundaram.   

Abstract

OBJECTIVES: To investigate the advantages and disadvantages of Totally implantable venous access devices (TIVAD) catheter in pediatric age group and also to review this subject in the recent literature and compare the results with the present results.
METHODS: A total of 61 cases, 2 mo to 14 y old, were included in the index study. TIVADs were implanted in these patients for chemotherapy. The device was inserted under general anesthesia (GA) by open technique. All the children were followed up for a mean period of 7.2 mo.
RESULTS: Out of 61 cases, 9 cases had complications; 3 requiring removal of the port due to infection and in one case the device had to be reinserted due to malpositioning, one had late wound dehiscence with exposed port chamber which needed operative correction and four had minor wound infections. There was no mortality. Complications like hemo or pneumothorax, arterial puncture, hematoma formation were very less with open technique of insertion of the port. Most patients and their parents were satisfied with TIVAD.
CONCLUSIONS: Thus, TIVAD can be a useful device for many chronic patients who need an IV access for multiple injections especially in pediatric age group.

Entities:  

Mesh:

Year:  2013        PMID: 23943575     DOI: 10.1007/s12098-013-1183-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  8 in total

1.  Totally implantable subpectoral vs. subcutaneous port systems in children with malignant diseases.

Authors:  Mohsen Rouzrokh; Bibi Shahin Shamsian; Ahmad KhaleghNejad Tabari; Morteza Mahmoodi; Jafar Kouranlo; Gholamreza Manafzadeh; Mohammad Taghi Arzanian; Fateme Fallah; Mahdieh Anoush; Fatemeh Abdollah Gorji
Journal:  Arch Iran Med       Date:  2009-07       Impact factor: 1.354

2.  Guidelines for the prevention of intravascular catheter-related infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

3.  Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.

Authors:  R Biffi; F Corrado; F de Braud; F de Lucia; D Scarpa; A Testori; F Orsi; M Bellomi; S Mauri; M Aapro; B Andreoni
Journal:  Eur J Cancer       Date:  1997-07       Impact factor: 9.162

4.  Totally implantable central venous access devices for paediatric oncology patients.

Authors:  F D Munro; P M Gillett; J C Wratten; M P Shaw; A Thomas; G A MacKinlay; W H Wallace
Journal:  Med Pediatr Oncol       Date:  1999-10

5.  Microbiology and risk factors for central line-associated bloodstream infections among pediatric oncology outpatients: a single institution experience of 41 cases.

Authors:  Matthew S Kelly; Margaret Conway; Kathleen E Wirth; Gail Potter-Bynoe; Amy L Billett; Thomas J Sandora
Journal:  J Pediatr Hematol Oncol       Date:  2013-03       Impact factor: 1.289

Review 6.  Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications.

Authors:  Isidoro Di Carlo; Elia Pulvirenti; Maurizio Mannino; Adriana Toro
Journal:  Ann Surg Oncol       Date:  2010-03-05       Impact factor: 5.344

7.  Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.

Authors:  R Biffi; F de Braud; F Orsi; S Pozzi; S Mauri; A Goldhirsch; F Nolè; B Andreoni
Journal:  Ann Oncol       Date:  1998-07       Impact factor: 32.976

8.  A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.

Authors:  C Araújo; J P Silva; P Antunes; J M Fernandes; C Dias; H Pereira; T Dias; J L Fougo
Journal:  Eur J Surg Oncol       Date:  2007-06-12       Impact factor: 4.424

  8 in total
  3 in total

1.  Analysis of related complications of totally implantable venous access ports in children's chemotherapy: Single center experience.

Authors:  Songze Zhang; Zhangsheng Xiao; Feibiao Yang
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

2.  External Jugular Venous Cutdown versus Percutaneous Technique for Chemoport Insertion in Children: A Comparative Study.

Authors:  Veerabhadra Radhakrishna; Chittur Narendra Radhakrishnan; Ravikiran Cheelenahalli Srinivasa Rao; Gollamandala Kireeti
Journal:  J Indian Assoc Pediatr Surg       Date:  2022-03-01

3.  Chemoport-A Savior in Children Who Require Chronic Venous Access: An Observational Study.

Authors:  Veerabhadra Radhakrishna; Chittur Narendra Radhakrishnan; Ravikiran Cheelenahalli Srinivasa Rao; Gollamandala Kireeti
Journal:  Vasc Specialist Int       Date:  2019-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.